Cas no 952138-19-1 (4-Chloro-7-methoxy-1,6-naphthyridine)

4-Chloro-7-methoxy-1,6-naphthyridine structure
952138-19-1 structure
Product Name:4-Chloro-7-methoxy-1,6-naphthyridine
CAS No:952138-19-1
MF:C9H7ClN2O
MW:194.61768078804
MDL:MFCD11848379
CID:830503
PubChem ID:59427318
Update Time:2025-11-07

4-Chloro-7-methoxy-1,6-naphthyridine Chemical and Physical Properties

Names and Identifiers

    • 4-Chloro-7-methoxy-1,6-naphthyridine
    • 4-chloro-7-methoxy-[1,6]naphthyridine
    • 4-Chloro-7-methoxy-1,6-naphthyridine (ACI)
    • MFCD11848379
    • AKOS016011713
    • SCHEMBL2208893
    • 952138-19-1
    • JOXFTPKSSCWINI-UHFFFAOYSA-N
    • DA-00259
    • DTXSID40731982
    • 4-Chloro-7-methoxy-[1.6]naphthyridine
    • AS-33696
    • CS-D0453
    • PB31606
    • CNB13819
    • MDL: MFCD11848379
    • Inchi: 1S/C9H7ClN2O/c1-13-9-4-8-6(5-12-9)7(10)2-3-11-8/h2-5H,1H3
    • InChI Key: JOXFTPKSSCWINI-UHFFFAOYSA-N
    • SMILES: ClC1C2C(=CC(OC)=NC=2)N=CC=1

Computed Properties

  • Exact Mass: 194.0246905g/mol
  • Monoisotopic Mass: 194.0246905g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 13
  • Rotatable Bond Count: 1
  • Complexity: 179
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.1
  • Topological Polar Surface Area: 35?2

Experimental Properties

  • Boiling Point: 303.4±37.0°C at 760 mmHg

4-Chloro-7-methoxy-1,6-naphthyridine Security Information

4-Chloro-7-methoxy-1,6-naphthyridine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A219007666-5g
4-Chloro-7-methoxy-1,6-naphthyridine
952138-19-1 95%
5g
$2000.00 2023-08-31
Alichem
A219007666-10g
4-Chloro-7-methoxy-1,6-naphthyridine
952138-19-1 95%
10g
$2917.89 2023-08-31
Alichem
A219007666-25g
4-Chloro-7-methoxy-1,6-naphthyridine
952138-19-1 95%
25g
$5500.44 2023-08-31
TRC
C375300-10mg
4-chloro-7-methoxy-1,6-naphthyridine
952138-19-1
10mg
$ 50.00 2022-04-01
TRC
C375300-50mg
4-chloro-7-methoxy-1,6-naphthyridine
952138-19-1
50mg
$ 210.00 2022-04-01
TRC
C375300-100mg
4-chloro-7-methoxy-1,6-naphthyridine
952138-19-1
100mg
$ 295.00 2022-04-01
CHENG DOU FEI BO YI YAO Technology Co., Ltd.
ARK-1711-5g
4-Chloro-7-Methoxy-1,6-naphthyridine
952138-19-1 95%
5g
$1700 2023-09-07
Chemenu
CM109188-1g
4-chloro-7-methoxy-1,6-naphthyridine
952138-19-1 95%
1g
$701 2021-08-06
abcr
AB440841-250 mg
4-Chloro-7-methoxy-1,6-naphthyridine, 95%; .
952138-19-1 95%
250mg
€652.80 2023-06-16
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1061729-100mg
4-Chloro-7-Methoxy-1,6-naphthyridine
952138-19-1 97%
100mg
¥1324.00 2024-04-24

4-Chloro-7-methoxy-1,6-naphthyridine Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Phosphorus oxychloride ;  3 h, rt
1.2 Reagents: Sodium bicarbonate Solvents: Water ;  pH 8, cooled
Reference
Arylaminophthalazine derivatives as Aurora kinase modulators and their preparation
, United States, , ,

Production Method 2

Reaction Conditions
1.1 Reagents: Diisopropylethylamine ,  Phosphorus oxychloride Solvents: Acetonitrile ;  rt; 30 min, 70 °C; 70 °C → rt
1.2 Reagents: Water ;  cooled
1.3 Reagents: Sodium hydroxide Solvents: Water ;  pH 8
Reference
Pyrido-azaheterocyclic compound as kinase inhibitor and its preparation
, China, , ,

Production Method 3

Reaction Conditions
1.1 Reagents: Phosphorus oxychloride ;  3 h, rt
1.2 Reagents: Sodium carbonate Solvents: Water ;  cooled; pH 8
Reference
Fused heterocyclic derivatives as HGF modulators and their preparation and methods of use
, United States, , ,

Production Method 4

Reaction Conditions
1.1 Reagents: Phosphorus oxychloride ;  3 h, rt
1.2 Reagents: Water ;  cooled
Reference
Phatalazinamine derivatives and related compounds as aurora kinase modulators and their preparation, pharmaceutical compositions and use in the treatment or cancer and cancer related diseases
, World Intellectual Property Organization, , ,

Production Method 5

Reaction Conditions
1.1 Reagents: Phosphorus oxychloride ;  3 h, rt
1.2 Reagents: Sodium carbonate Solvents: Water ;  pH 8, cooled
Reference
Preparation of fused heterocyclic derivatives for treating HGF mediated diseases
, World Intellectual Property Organization, , ,

Production Method 6

Reaction Conditions
1.1 Reagents: Diisopropylethylamine ,  Phosphorus oxychloride Solvents: 1,4-Dichlorobenzene ;  rt → 10 °C; 1.5 h, 10 °C → 70 °C; 70 °C → rt
Reference
Preparation of naphthyridine derivatives as anti-cancer agents
, World Intellectual Property Organization, , ,

4-Chloro-7-methoxy-1,6-naphthyridine Raw materials

4-Chloro-7-methoxy-1,6-naphthyridine Preparation Products

4-Chloro-7-methoxy-1,6-naphthyridine Related Literature

Recommended suppliers
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd
Shanghai Aoguang Biotechnology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Aoguang Biotechnology Co., Ltd